Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

449 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons.
Spear GT, Olinger G, Sullivan BL, Landay AL, Kessler H, Connick E, Kuritzkes D, St Clair M, Spritzler J, Wu H, Lederman MM. Spear GT, et al. Among authors: lederman mm. AIDS Res Hum Retroviruses. 1999 Dec 10;15(18):1713-5. doi: 10.1089/088922299309766. AIDS Res Hum Retroviruses. 1999. PMID: 10606095 Clinical Trial. No abstract available.
Human immunodeficiency virus type 1 activation after blood transfusion.
Mudido PM, Georges D, Dorazio D, Yen-Lieberman B, Bae S, O'Brien WA, Spritzler J, Lederman MM. Mudido PM, et al. Among authors: lederman mm. Transfusion. 1996 Oct;36(10):860-5. doi: 10.1046/j.1537-2995.1996.361097017170.x. Transfusion. 1996. PMID: 8863771
Rationale for immune-based therapies for HIV-1 infection.
Valdez H, Al-Harthi L, Landay A, Lederman MM. Valdez H, et al. Among authors: lederman mm. J Lab Clin Med. 1998 Mar;131(3):197-206. doi: 10.1016/s0022-2143(98)90090-7. J Lab Clin Med. 1998. PMID: 9523842 Review. No abstract available.
In vivo analysis of Fas/FasL interactions in HIV-infected patients.
Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E, Kessler H, Kuritzkes D, Lynch DH, Roche P, Yagita H, Paya CV. Badley AD, et al. Among authors: lederman mm. J Clin Invest. 1998 Jul 1;102(1):79-87. doi: 10.1172/JCI2691. J Clin Invest. 1998. PMID: 9649560 Free PMC article.
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.
Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St Clair M, Kotzin BL, Fox L, Chiozzi MH, Leonard JM, Rousseau F, Wade M, Roe JD, Martinez A, Kessler H. Lederman MM, et al. J Infect Dis. 1998 Jul;178(1):70-9. doi: 10.1086/515591. J Infect Dis. 1998. PMID: 9652425 Clinical Trial.
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end points.
Wu H, Kuritzkes DR, McClernon DR, Kessler H, Connick E, Landay A, Spear G, Heath-Chiozzi M, Rousseau F, Fox L, Spritzler J, Leonard JM, Lederman MM. Wu H, et al. Among authors: lederman mm. J Infect Dis. 1999 Apr;179(4):799-807. doi: 10.1086/314670. J Infect Dis. 1999. PMID: 10068574
449 results